Burning Rock Biotech

BNR · NASDAQ

$12.66+$0.37 (+3.01%)TodayMarket closed · Oct 20, 4:10 PM ET

Prev close $12.29

About BNR

Burning Rock Biotech Ltd. engages in the investment of medical fields. The firm operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.

Employees: 667
Headquarters: Guangzhou, Guangdong
Listed: Jun 12, 2020
Sector: Health Care
Industry: Biotechnology
Website: brbiotech.com

Leadership

Burning Rock Biotech executives
Name	Title	Since	Age
Yusheng Han	—	—	46
Xiaozhi Hu	—	—	41
Zhihong Zhang	—	2016	49
Feng Deng	—	—	61
Gang Lu	—	—	53
Wendy Hayes	—	—	55
Lisa Xu	—	—	59

Revenue by product and region

Fiscal year ended Dec 31, 2025: $539.57M total revenue

By product

Service [Member]$45.20M8.4%
Product [Member]$31.95M5.9%

By region

Geographic Distribution, Foreign [Member]$62.73M11.6%
Geographic Distribution, Domestic [Member]$14.43M2.7%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Burning Rock Biotech suppliers and customers
Company	Relationship	Country	Correlation
Oncocyte OCX	Supplier and customer	US	0.98
Illumina ILMN	Supplier and customer	US	0.90
Myriad Genetics MYGN	Supplier and customer	US	0.81
BeiGene	Customer	CN	0.70
CStone Pharmaceuticals	Supplier and customer	CN	0.64
Johnson & Johnson JNJ	Customer	US	-0.31
Bayer BAYN.DE	Supplier and customer	DE	-0.41
AstraZeneca AZN.L	Customer	GB	-0.58
Abbisko Therapeutics Co., Ltd.	Supplier and customer	CN	—

Similar companies

Companies in the same industry as Burning Rock Biotech

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.